HomepageAKUMS • NSE
add
Akums Drugs and Pharmaceuticals Ltd
Vorige slotkoers
₹ 529,95
Dag-range
₹ 510,00 - ₹ 543,00
Jaar-range
₹ 405,00 - ₹ 1.175,90
Beurswaarde
81,22 mld. INR
Gem. volume
438,94K
Koers/winst
-
Dividendrendement
-
Primaire beurs
NSE
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(INR) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 10,10 mld. | -6,69% |
Bedrijfskosten | 3,31 mld. | 4,68% |
Netto inkomsten | 651,82 mln. | -66,35% |
Netto winstmarge | 6,45 | -63,95% |
Winst per aandeel | — | — |
EBITDA | 1,05 mld. | -0,66% |
Effectief belastingtarief | 27,17% | — |
Balans
Totale activa
Totale passiva
(INR) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 7,95 mld. | — |
Totale activa | — | — |
Totale passiva | — | — |
Totaal aandelenvermogen | 28,47 mld. | — |
Uitstaande aandelen | 153,01 mln. | — |
Koers-boekwaardeverhouding | 2,79 | — |
Rendement op activa | — | — |
Rendement op kapitaal | 5,69% | — |
Kasstroom
Nettomutatie in liquide middelen
(INR) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 651,82 mln. | -66,35% |
Operationele kasstroom | — | — |
Kasstroom uit beleggingen | — | — |
Kasstroom uit financiering | — | — |
Nettomutatie in liquide middelen | — | — |
Vrije kasstroom | — | — |
Over
Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical Contract Development and Manufacturing Organization that serves both domestic and multinational pharmaceutical companies. The company was established in 2004 and became publicly listed on 6 August 2024.
Akums is India's largest Contract Development and Manufacturing Organization, driving pharmaceutical innovation and excellence in the Indian Pharmaceutical Market. From inception it has developed over 4,100 commercialized formulations across 60+ dosage forms, catering to key therapeutic areas such as cardio-diabetes, neurology, gynecology, nephrology, anti-infectives, respiratory, analgesics, and multi-vitamins. Our robust R&D capabilities have led to 220+ innovative formulations, supported by 22+ versatile platform technologies that enhance product development and differentiation. Wikipedia
Opgericht
2004
Website
Werknemers
7.388